These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29388034)

  • 1. Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastoma.
    Jackson WC; Tsien CI; Junck L; Leung D; Hervey-Jumper S; Orringer D; Heth J; Wahl DR; Spratt DE; Cao Y; Lawrence TS; Kim MM
    J Neurooncol; 2018 May; 138(1):155-162. PubMed ID: 29388034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options and outcomes for glioblastoma in the elderly patient.
    Arvold ND; Reardon DA
    Clin Interv Aging; 2014; 9():357-67. PubMed ID: 24591820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513.
    Brachman DG; Pugh SL; Ashby LS; Thomas TA; Dunbar EM; Narayan S; Robins HI; Bovi JA; Rockhill JK; Won M; Curran WP
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):961-7. PubMed ID: 25832688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy.
    Tini P; Nardone V; Pastina P; Battaglia G; Miracco C; Sebaste L; Rubino G; Cerase A; Pirtoli L
    Biomed Res Int; 2017; 2017():9461402. PubMed ID: 29159183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial.
    Toms SA; Kim CY; Nicholas G; Ram Z
    J Neurooncol; 2019 Jan; 141(2):467-473. PubMed ID: 30506499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of very elderly glioblastoma patients ≥ 75 years of age: whom to treat.
    Baumgarten P; Prange G; Kamp MA; Monden D; Neef V; Schwarzer F; Dubinski D; Dinc N; Weber KJ; Czabanka M; Hattingen E; Ronellenfitsch MW; Steinbach JP; Senft C
    J Neurooncol; 2023 Dec; 165(3):509-515. PubMed ID: 38032426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Randomized Phase 2 Trial of Hypofractionated Stereotactic Radiation Therapy of 25 Gy in 5 Fractions Compared With 35 Gy in 5 Fractions in the Reirradiation of Recurrent Glioblastoma.
    Chen ATC; Serante AR; Ayres AS; Tonaki JO; Moreno RA; Shih H; Gattás GS; Lopez RVM; Dos Santos de Jesus GR; de Carvalho IT; Marotta RC; Marta GN; Feher O; Neto HS; Ribeiro ISN; Vasconcelos KGMDC; Figueiredo EG; Weltman E
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(4):1122-1132. PubMed ID: 38232937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).
    Gately L; Mesía C; Sepúlveda JM; Del Barco S; Pineda E; Gironés R; Fuster J; Dumas M; Gill S; Navarro LM; Herrero A; Dowling A; de Las Peñas R; Vaz MA; Alonso M; Lwin Z; Harrup R; Peralta S; Long A; Perez-Segura P; Ahern E; Garate CO; Wong M; Campbell R; Cuff K; Jennens R; Gallego O; Underhill C; Martinez-Garcia M; Covela M; Cooper A; Brown S; Rosenthal M; Torres J; Collins IM; Gibbs P; Balana C
    J Neurooncol; 2024 Jun; 168(2):299-306. PubMed ID: 38630385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant Radiation in Older Patients With Glioblastoma: A Retrospective Single Institution Analysis.
    Lee JW; Kirkpatrick JP; McSherry F; Herndon JE; Lipp ES; Desjardins A; Randazzo DM; Friedman HS; Ashley DM; Peters KB; Johnson MO
    Front Oncol; 2021; 11():631618. PubMed ID: 33732649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous boost radiotherapy versus conventional dose radiotherapy for patients with newly diagnosed glioblastoma: a multi-institutional analysis.
    Takano S; Tomita N; Kuno M; Niwa M; Torii A; Takaoka T; Kita N; Okazaki D; Yamamoto S; Kawai T; Sugie C; Ogawa Y; Matsumoto K; Uchiyama K; Otsuka S; Matsui T; Miyakawa A; Mizuno T; Iida M; Tanikawa M; Mase M; Hiwatashi A
    Sci Rep; 2024 Apr; 14(1):9283. PubMed ID: 38654028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial).
    Laprie A; Noel G; Chaltiel L; Truc G; Sunyach MP; Charissoux M; Magne N; Auberdiac P; Biau J; Ken S; Tensaouti F; Khalifa J; Sidibe I; Roux FE; Vieillevigne L; Catalaa I; Boetto S; Uro-Coste E; Supiot S; Bernier V; Filleron T; Mounier M; Poublanc M; Olivier P; Delord JP; Cohen-Jonathan-Moyal E
    Neuro Oncol; 2024 Jan; 26(1):153-163. PubMed ID: 37417948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Strategies for Glioblastoma in the Elderly: What Should We Focus on Compared to Younger Patients.
    Gull HH; Von Riegen AC; Beckmann GT; Ketelauri P; Walbrodt S; Santos AN; Oster C; Schmidt T; Glas M; Jabbarli R; Özkan N; Dammann P; Scheffler B; Sure U; Ahmadipour Y
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Factors for Progression-free Survival and Overall Survival After Recurrence of Glioblastoma.
    Zemskova O; Yu NY; Leppert J; Rades D
    Anticancer Res; 2024 Jul; 44(7):3059-3066. PubMed ID: 38925836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The addition of Valproic acid to concurrent radiation therapy and temozolomide improves patient outcome: a Correlative analysis of RTOG 0525, SEER and a Phase II NCI trial.
    Krauze AV; Megan M; Theresa CZ; Peter M; Shih JH; Tofilon PJ; Rowe L; Gilbert M; Camphausen K
    Cancer Stud Ther; 2020 Mar; 5(1):. PubMed ID: 34621499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative MRI for newly diagnosed supratentorial glioblastoma: a multicenter-registry comparative study to conventional surgery.
    Shah AS; Sylvester PT; Yahanda AT; Vellimana AK; Dunn GP; Evans J; Rich KM; Dowling JL; Leuthardt EC; Dacey RG; Kim AH; Grubb RL; Zipfel GJ; Oswood M; Jensen RL; Sutherland GR; Cahill DP; Abram SR; Honeycutt J; Shah M; Tao Y; Chicoine MR
    J Neurosurg; 2020 Oct; 135(2):505-514. PubMed ID: 33035996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of glioblastoma patients improves significantly over time interrogating historical controls.
    Thomas-Joulié A; Tran S; El Houari L; Seyve A; Bielle F; Birzu C; Lozano-Sanchez F; Mokhtari K; Giry M; Marie Y; Laigle-Donadey F; Dehais C; Houillier C; Psimaras D; Alentorn A; Laurenge A; Touat M; Sanson M; Hoang-Xuan K; Kas A; Rozenblum L; Habert MO; Nichelli L; Leclercq D; Galanaud D; Jacob J; Karachi C; Capelle L; Carpentier A; Mathon B; Belin L; Idbaih A
    Eur J Cancer; 2024 May; 202():114004. PubMed ID: 38493668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma and radiotherapy: A multicenter AI study for Survival Predictions from MRI (GRASP study).
    Chelliah A; Wood DA; Canas LS; Shuaib H; Currie S; Fatania K; Frood R; Rowland-Hill C; Thust S; Wastling SJ; Tenant S; McBain C; Foweraker K; Williams M; Wang Q; Roman A; Dragos C; MacDonald M; Lau YH; Linares CA; Bassiouny A; Luis A; Young T; Brock J; Chandy E; Beaumont E; Lam TC; Welsh L; Lewis J; Mathew R; Kerfoot E; Brown R; Beasley D; Glendenning J; Brazil L; Swampillai A; Ashkan K; Ourselin S; Modat M; Booth TC
    Neuro Oncol; 2024 Jun; 26(6):1138-1151. PubMed ID: 38285679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of radiation fractionation regimens on glioblastoma.
    McKelvey KJ; Hudson AL; Donaghy H; Stoner SP; Wheeler HR; Diakos CI; Howell VM
    Radiat Oncol; 2022 Jan; 17(1):17. PubMed ID: 35073960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcomes and prognostic factors of infratentorial glioblastoma in the elderly.
    Chandra A; Lopez-Rivera V; Ryba B; Chandran AS; Brandel MG; Dono A; Sheinberg DL; Esquenazi YL; Aghi MK
    Clin Neurol Neurosurg; 2024 Jan; 236():108084. PubMed ID: 38141552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does waiting for surgery matter? How time from diagnostic MRI to resection affects outcomes in newly diagnosed glioblastoma.
    Young JS; Al-Adli NN; Muster R; Chandra A; Morshed RA; Pereira MP; Chalif EJ; Hervey-Jumper SL; Theodosopoulos PV; McDermott MW; Berger MS; Aghi MK
    J Neurosurg; 2024 Jan; 140(1):80-93. PubMed ID: 37382331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.